Is XenoPort, Inc. (XNPT) Going to Burn These Hedge Funds?
At the moment, there are plenty of metrics market participants can use to monitor the equity markets. A pair of the most underrated are hedge fund and insider trading activity.
Obagi Medical Products Inc. (OMPI)
Market is closed
News
- 1 - 10
- Next >>
XenoPort, Inc. (XNPT): Hedge Funds and Insiders Are Bearish, What Should You Do?
Is XenoPort, Inc. (NASDAQ:XNPT) a healthy stock for your portfolio? Money managers are in a pessimistic mood.
Do Hedge Funds and Insiders Love AVEO Pharmaceuticals, Inc. (AVEO)?
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) was in 9 hedge funds' portfolio at the end of the first quarter of 2013.
Should You Buy Obagi Medical Products, Inc. (OMPI)?
According to most traders, hedge funds are perceived as underperforming, outdated financial tools of years past.
Should You Buy 3SBio Inc. (ADR) (SSRX)?
In today’s marketplace, there are plenty of gauges market participants can use to watch Mr. Market. Two of the most under-the-radar are hedge fund and insider trading interest.
Biopharma News: Amarin Corporation plc (ADR) (AMRN), GlaxoSmithKline plc (ADR) (GSK), Abbott Laboratories (ABT)
Editor's Note: Related Tickers: Amarin Corporation plc (ADR) (NASDAQ:AMRN), GlaxoSmithKline plc (ADR) (NYSE:GSK), Abbott Laboratories (NYSE:ABT), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Obagi Medical...
Hedge Funds Are Dumping Obagi Medical Products, Inc. (OMPI)
Obagi Medical Products, Inc. (NASDAQ:OMPI) was in 7 hedge funds' portfolio at the end of December. OMPI has seen a decrease in activity from the world's largest hedge funds recently.
Hedge Funds Are Betting On AVEO Pharmaceuticals, Inc. (AVEO)
To the average investor, there are plenty of indicators investors can use to monitor their holdings. Two of the most under-the-radar are hedge fund and insider trading interest.
Should You Buy AVEO Pharmaceuticals, Inc. (AVEO)?
To most shareholders, hedge funds are assumed to be unimportant, outdated investment tools of yesteryear.
GlaxoSmithKline plc (ADR) (GSK) & Three Humongous Healthcare Stocks This Week
Last week, Obagi Medical Products, Inc. (NASDAQ:OMPI) made our list of humongous performers after Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced a $344 million bid for the company.
- 1 - 10
- Next >>
Billionaire Hedge Funds
